ArticleJournal of neuro-oncology2024

PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.

Shizun Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.